Immunologists from the Institute have been the first to uncover a role for a family of RNA binding proteins in the function ...

Scientists at the McGovern Institute and the Broad Institute of MIT and Harvard have reengineered a compact RNA-guided enzyme ...

Current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products.

The CRISPR-Cas9 patent landscape remains complex and unsettled. The Federal Circuit’s latest decision in University of California v.

N of 1 therapy uniquely developed for infant with life-threatening rare metabolic disorder in six months by Aldevron and ...

In a precedential opinion issued on Monday, the U.S. Court of Appeals for the Federal Circuit (CAFC) vacated and remanded a ...

Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a ...

Get our top picks of the posters at AACR 2025 and learn more about the method behind them and the techniques used.

Aldevron and Integrated DNA Technologies – both part of the Danaher Corporation – have achieved a medical milestone with the ...

In a world first, scientists used CRISPR to fix a baby's unique genetic mutation. The report offers hope for personalized ...

Treated with an individualized gene-editing therapy that corrects mutations directly on the genome, a patient shows ...